Conference Coverage

VIDEO: Health advisers boost type 2 diabetes adherence


 

REPORTING FROM AACE 2018

– A company that partners patients and health advisers claims to help patients with type 2 diabetes to manage their symptoms and lower their HbA1c levels.

The Pack Health program connects each patient with a health adviser, who contacts them five times a week using a mix of phone calls, text messages, and emails. The goals include helping patients to find clinicians in their area, make appointments, and adhere to treatment, Dhiren Patel, PharmD, medical director at Pack Health, said at the annual meeting of the American Association of Clinical Endocrinologists.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

In a prospective study of 756 type 2 diabetes patients, traditional modes of communication with a health coach were associated with a 1% decrease in HbA1c within 3 months and the reduction was maintained at 1 year. Patients lost an average of 5 pounds, and annual eye and foot exams increased by 17% and 19%, respectively.

Similar remote health coach initiatives are being used to help other patients with chronic health conditions as part of the Pack Health services, which Dr. Patel discussed in a video interview.

SOURCE: Patel D et al. AACE 2018. Abstract 1209.

Recommended Reading

VIDEO: First year after bariatric surgery critical for HbA1c improvement
Type 2 Diabetes ICYMI
SCVD common in women with type 1 diabetes
Type 2 Diabetes ICYMI
Trends in teen consumption of sports drinks are up and down
Type 2 Diabetes ICYMI
Do “VILPs” signal a new era for viral endocrinology?
Type 2 Diabetes ICYMI
VIDEO: Real-world findings on hybrid closed-loop insulin system
Type 2 Diabetes ICYMI
Hematocrit improvement with SGLT2 inhibitor: Not just a diuretic effect?
Type 2 Diabetes ICYMI
VIDEO: Diabetes patients achieve lipid goals on alirocumab
Type 2 Diabetes ICYMI
VIDEO: Move beyond BMI to see obesity as a disease
Type 2 Diabetes ICYMI
VIDEO: Canagliflozin’s HbA1c effect muted over time by placebo group effects
Type 2 Diabetes ICYMI
Canagliflozin linked to lower HbA1c levels in younger patients
Type 2 Diabetes ICYMI